ホーム > 市場調査レポート > 医薬品

市場調査レポート

商品コード

1741405

規制薬物市場：薬剤クラス別、用途別、販売チャネル別、地域別

Controlled Substance Market, By Drug Class, By Application, By Sales Channel, By Geography

出版日: 2025年03月27日
発行: Coherent Market Insights
ページ情報: 英文 175 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 653,040円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,015,840円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,451,200円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.12円

全表示
概要
目次

概要

サンプル依頼リストに入れる

規制薬物市場は2025年に460億米ドルと推定され、2032年には643億米ドルに達する見込みで、2025年から2032年までの年間平均成長率（CAGR）で4.9%の成長が予測されています。

レポート範囲		レポート詳細
基準年	2024	2025年の市場規模	460億米ドル
実績データ	2020年から2024年まで	予測期間	2025年から2032年
予測期間：2025年～2032年 CAGR：	4.90%	2032年の価値予測	643億米ドル

世界の規制薬物市場は、製薬業界の中でも高度に規制された専門分野です。規制薬物とは、乱用や依存の可能性がある薬物のことで、そのため政府の厳しい規制の対象となっています。これらの物質は、医療用途、乱用の可能性、安全性プロファイルに基づいて、さまざまなスケジュールに分類されます。

市場力学：

世界の規制薬物市場の市場力学は、様々な要因の影響を受けています。市場促進要因としては、慢性疾患の増加、疼痛管理薬に対する需要の高まり、老人人口の増加などが挙げられます。一方、厳しい政府規制、薬物乱用や中毒のリスク、研究開発コストの高さなどが市場の抑制要因となっています。

しかし、市場には成長の機会もあります。新規ドラッグデリバリーシステムの開発、技術の進歩、個別化医療への注目の高まりが市場成長の原動力になると予想されます。さらに、新興国における医療インフラの拡大や、精神疾患に対する意識の高まりは、市場関係者にとって新たな道を切り開くものです。

結論として、世界の規制薬物市場は、製薬業界の中でも高度に規制され専門化された分野です。市場力学は、政府の規制、市場促進要因、抑制要因、機会など、さまざまな要因の影響を受けています。市場の主なプレーヤーは、疼痛管理や慢性疾患治療の需要拡大に対応するため、規制薬物の研究開発および流通に注力しています。

本調査の主な特徴

世界の規制薬物市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模および複合年間成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて解説しています。
また市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の規制薬物市場における主要企業プロファイルを掲載しています。
本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
世界の規制薬物市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
利害関係者は、世界の規制薬物市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

企業プロファイル
- Johnson &Johnson Services, Inc.
- Pfizer Inc.
- Sanofi
- Merck &Co., Inc.
- Gilead Sciences, Inc.
- Amgen Inc.
- Novartis Pharmaceuticals Corporation
- AbbVie Inc.
- GSK Plc.
- AstraZeneca
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Teva Pharmaceutical Inc.
- Bayer AG
- Novo Nordisk A/S
- Takeda Pharmaceutical Company Limited
- Boehringer Ingelheim International GmbH
- Aspen Holdings
- Astellas Pharma Inc.
アナリストの見解

第10章セクション

参考文献
調査手法
出版社について

Product Code: CMI6201

Controlled Substance Market is estimated to be valued at USD 46.00 Bn in 2025 and is expected to reach USD 64.3 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.9% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 46.00 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.90%	2032 Value Projection:	USD 64.3 Bn

The global controlled substance market is a highly regulated and specialized sector within the pharmaceutical industry. Controlled substances are drugs that have the potential for abuse and dependence, and are therefore subject to strict government regulations. These substances are classified into different schedules based on their medical use, potential for abuse, and safety profile.

Market Dynamics:

The market dynamics of the global controlled substance market are influenced by various factors. The drivers of the market include the increasing prevalence of chronic diseases, rising demand for pain management drugs, and the growing geriatric population. On the other hand, the market is restrained by stringent government regulations, the risk of drug abuse and addiction, and the high cost of research and development.

However, the market also presents opportunities for growth. The development of novel drug delivery systems, advancements in technology, and the increasing focus on personalized medicine are expected to drive market growth. Additionally, the expansion of healthcare infrastructure in emerging economies and the growing awareness about mental health disorders are creating new avenues for market players.

In conclusion, the global controlled substance market is a highly regulated and specialized sector within the pharmaceutical industry. The market dynamics are influenced by various factors, including government regulations, market drivers, restraints, and opportunities. The key players in the market are focused on research, development, and distribution of controlled substances to meet the growing demand for pain management and chronic disease treatment.

Key features of the study:

This report provides in-depth analysis of the global controlled substance market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global controlled substance market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Johnson & Johnson, Pfizer, Sanofi, Merck & Co., Gilead Sciences, Amgen, Novartis, AbbVie, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Teva Pharmaceutical, Bayer, Novo Nordisk, Allergan, Takeda Pharmaceutical, Boehringer Ingelheim, Aspen Pharmacare, and Astellas Pharma. These companies are involved in the research, development, manufacturing, and distribution of controlled substances
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global controlled substance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global controlled substance market

Detailed Segmentation:

Global Controlled Substance Market, By Drug Type:
- Opioids
- Stimulants
- Depressants
- Hallucinogens
- Anabolic Steroids
Global Controlled Substance Market, By Application:
- Pain Management
- Anxiety
- Insomnia
- Cough Suppression
- ADHD
- Narcolepsy
Global Controlled Substance Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Controlled Substance Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- Johnson & Johnson
- Pfizer
- Sanofi
- Merck & Co.
- Gilead Sciences
- Amgen
- Novartis
- AbbVie
- GlaxoSmithKline
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly
- Teva Pharmaceutical
- Bayer
- Novo Nordisk
- Allergan
- Takeda Pharmaceutical
- Boehringer Ingelheim
- Aspen Pharmacare
- Astellas Pharma

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Application
- Market Snippet, By Sales Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Controlled Substance Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Controlled Substance Market, By Drug Class, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Stimulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Depressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Hallucinogens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Anabolic Steroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Controlled Substance Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Anxiety
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Insomnia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Cough Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Attention Deficit Hyperactivity Disorder (ADHD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Narcolepsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Controlled Substance Market, By Sales Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others (Academic & Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Controlled Substance Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region , 2020-2032, (US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Company Profile
- Johnson & Johnson Services, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Pfizer Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Sanofi
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Gilead Sciences, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Amgen Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Novartis Pharmaceuticals Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- AbbVie Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- GSK Plc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- AstraZeneca
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Bristol-Myers Squibb Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Eli Lilly and Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Teva Pharmaceutical Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Bayer AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Novo Nordisk A/S
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Takeda Pharmaceutical Company Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Boehringer Ingelheim International GmbH
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Aspen Holdings
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Astellas Pharma Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analysts' Views

10. Section

References
Research Methodology
About us

ライセンス / 価格

PDF (Single User License)

USD 4,500 653,040円

その他のライセンス / 価格

PDF (Multi User License)

USD 7,000 1,015,840円

PDF (Enterprise User License)

USD 10,000 1,451,200円

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.12円

お電話でのお問い合わせ

044-952-0102

( 土日・祝日を除く )

薬物

規制薬物市場：薬剤クラス別、用途別、販売チャネル別、地域別

Controlled Substance Market, By Drug Class, By Application, By Sales Channel, By Geography

市場力学：

本調査の主な特徴

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の規制薬物市場 - コロナウイルス（COVID-19）パンデミックの影響

第5章世界の規制薬物市場、薬剤クラス別、2020年～2032年

第6章世界の規制薬物市場、用途別、2020年～2032年

第7章世界の規制薬物市場、販売チャネル別、2020年～2032年

第8章世界の規制薬物市場、地域別、2020年～2032年

第9章競合情勢

第10章セクション

Market Dynamics:

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Controlled Substance Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Controlled Substance Market, By Drug Class, 2020-2032, (US$ Bn)

6. Global Controlled Substance Market, By Application, 2020-2032, (US$ Bn)

7. Global Controlled Substance Market, By Sales Channel, 2020-2032, (US$ Bn)

8. Global Controlled Substance Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

規制薬物市場：薬剤クラス別、用途別、販売チャネル別、地域別

Controlled Substance Market, By Drug Class, By Application, By Sales Channel, By Geography

市場力学：

本調査の主な特徴

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界の規制薬物市場 - コロナウイルス（COVID-19）パンデミックの影響

第5章 世界の規制薬物市場、薬剤クラス別、2020年～2032年

第6章 世界の規制薬物市場、用途別、2020年～2032年

第7章 世界の規制薬物市場、販売チャネル別、2020年～2032年

第8章 世界の規制薬物市場、地域別、2020年～2032年

第9章 競合情勢

第10章 セクション

Market Dynamics:

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Controlled Substance Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Controlled Substance Market, By Drug Class, 2020-2032, (US$ Bn)

6. Global Controlled Substance Market, By Application, 2020-2032, (US$ Bn)

7. Global Controlled Substance Market, By Sales Channel, 2020-2032, (US$ Bn)

8. Global Controlled Substance Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の規制薬物市場 - コロナウイルス（COVID-19）パンデミックの影響

第5章世界の規制薬物市場、薬剤クラス別、2020年～2032年

第6章世界の規制薬物市場、用途別、2020年～2032年

第7章世界の規制薬物市場、販売チャネル別、2020年～2032年

第8章世界の規制薬物市場、地域別、2020年～2032年

第9章競合情勢

第10章セクション